Additionally, understanding the regulatory mechanisms of LOX expression could lead to novel therapeutic approaches, such as targeting upstream signaling pathways or combining LOX inhibition with immunotherapy to enhance anti - tumor immune responses (91–93). The gene discussed is LOX; the disease is neoplasm.